Literature DB >> 12150593

Neonatal mydriasis: intravenous lidocaine adverse reaction.

Itai Berger1, Avraham Steinberg, Yechtiel Schlesinger, Mordechai Seelenfreund, Michael S Schimmel.   

Abstract

Lidocaine (a sodium channel blocker) serves as an antiepilepsy drug in neonates. We present a neonate with a seizure disorder who acutely developed pupillary mydriasis secondary to lidocaine overdose. We suggest adding this side effect to the list of untoward effects of lidocaine and to the differential diagnosis of fixed dilated pupils in neonates treated with lidocaine.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12150593     DOI: 10.1177/088307380201700520

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  2 in total

1.  Development of an optimal lidocaine infusion strategy for neonatal seizures.

Authors:  Mirte M Malingré; Linda G M Van Rooij; Carin M A Rademaker; Mona C Toet; Tessa F F T Ververs; Charlotte van Kesteren; Linda S de Vries
Journal:  Eur J Pediatr       Date:  2006-05-12       Impact factor: 3.183

2.  Cardiac arrhythmias in neonates receiving lidocaine as anticonvulsive treatment.

Authors:  Linda G M van Rooij; Mona C Toet; Karin M A Rademaker; Floris Groenendaal; Linda S de Vries
Journal:  Eur J Pediatr       Date:  2004-08-07       Impact factor: 3.183

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.